Kiniksa Pharmaceuticals International CAO Michael R. Megna Sells $1.11M of Stock
Michael R. Megna, CAO, sold 11,280 shares of Kiniksa Pharmaceuticals International, plc at $98.54 a share, worth $1.11M in total on Nov 9, 2026. Shares held after the trade: 12,697 (-47.0%).
Kiniksa Pharmaceuticals International Chairman & CEO Sanj K. Patel Sells $14.3M of Stock
Sanj K. Patel, Chairman & CEO, sold 151,300 shares of Kiniksa Pharmaceuticals International, plc at $92.35 to $96.05 a share (average $94.71) in 5 transactions, worth $14.3M in total on Nov 4, 2026. Shares held after the trade: 774,500 (-3.4%).
Kiniksa Pharmaceuticals International Chairman & CEO Sanj K. Patel Sells $37.4M of Stock
Sanj K. Patel, Chairman & CEO, sold 402,394 shares of Kiniksa Pharmaceuticals International, plc at $90.77 to $98.16 a share (average $92.92) in 14 transactions, worth $37.4M in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 780,037 (-0.6%).
Kiniksa Pharmaceuticals International CFO Mark Ragosa Sells $3.39M of Stock
Mark Ragosa, CFO, sold 36,783 shares of Kiniksa Pharmaceuticals International, plc at $91.40 to $94.01 a share (average $92.16) in 4 transactions, worth $3.39M in total on Nov 2, 2026. Shares held after the trade: 20,854 (-1.0%).
Kiniksa Pharmaceuticals International CMO John F. Paolini Sells $8.94M of Stock
John F. Paolini, CMO, sold 96,000 shares of Kiniksa Pharmaceuticals International, plc at $92.02 to $97.77 a share (average $93.09) in 10 transactions, worth $8.94M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 69,922 (-1.0%).
Kiniksa Pharmaceuticals International COO Ross Moat Sells $9.63M of Stock
Ross Moat, COO, sold 103,585 shares of Kiniksa Pharmaceuticals International, plc at $91.23 to $97.76 a share (average $92.93) in 11 transactions, worth $9.63M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 10,294 (-6.6%).
Kiniksa Pharmaceuticals International CAO Michael R. Megna Sells $3.42M of Stock
Michael R. Megna, CAO, sold 36,260 shares of Kiniksa Pharmaceuticals International, plc at $91.87 to $97.74 a share (average $94.43) in 7 transactions, worth $3.42M in total on Oct 30, 2026. Shares held after the trade: 12,697 (-29.6%).